Collectively, these results suggest that IRG1-mediated T-cell exhaustion and tumorigenesis depend on itaconate levels both in vitro and in vivo and that macrophage-derived itaconate indirectly promotes tumor growth by suppressing CD8+ T-cell activity. Here, CD8A is linked to neoplasm.